Clinical trials recruiting in Torpoint, United Kingdom
5
Recruiting trials
8
Conditions
Phase breakdown
Phase 2 1Phase 3 4
Conditions recruiting in Torpoint, United Kingdom
| Condition | Trials |
|---|---|
| Obesity | 3 |
| Overweight | 2 |
| Type 2 Diabetes | 2 |
| Atherosclerosis Cardiovascular Disease | 1 |
| Chronic Kidney Disease | 1 |
| High Cardiovascular Risk | 1 |
| High Risk Cardiovascular Disease | 1 |
| Hypertension | 1 |
Recruiting trials in Torpoint, United Kingdom
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Common questions
How many clinical trials are recruiting in Torpoint, United Kingdom?
5 recruiting trials have at least one study site in Torpoint, United Kingdom.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.